💨 Abstract

The US Food and Drug Administration (FDA) has approved the nasal influenza vaccine FluMist by AstraZeneca for self-administration, making it the first such vaccine in the US. It is administered via a spray in the nose and can be taken by individuals aged 2 to 49. The vaccine contains a weakened form of live influenza virus strains and is sprayed in the nose, and a prescription is still required to receive it.

Courtesy: theprint.in